Thymmune Therapeutics
About:
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.
Website: https://www.thymmune.com/
Top Investors: Arranta Bio, Advanced Research Projects Agency for Health, Pillar VC, NYBC Ventures, George Church
Description:
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Total Funding Amount:
$44M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)thymmune.com
Founders:
Stan Wang
Number of Employees:
1-10
Last Funding Date:
2023-09-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai